Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Favorable preclinical profile of novel HIV integrase inhibitor INH-I001

Feb. 14, 2008

SCH-532706 safe and well tolerated in combination with ritonavir

Feb. 13, 2008

Preliminary clinical data show significant HIV viral load reduction with IDX-899

Feb. 13, 2008

Novel therapeutic agents for HIV infection disclosed in patent literature

Feb. 11, 2008

Study shows efficacy of once-daily atazanavir sulfate/ritonavir in HIV patients

Feb. 8, 2008

Studies show safety and efficacy of elvucitabine in HIV

Feb. 4, 2008

Lipid reports favorable results from preclinical study of delipidated autologous virus vaccine

Feb. 1, 2008

Theratechnologies reviews strategic alternatives to enhance shareholder value

Feb. 1, 2008

New HIV integrase inhibitor developed at Merck Research Laboratories

Jan. 31, 2008

New agents for treating HIV infection reported in recent patent literature

Jan. 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...